Craft

e-therapeutics

Total Funding

$66.8 M

e-therapeutics Summary

Company Summary

Overview
e-therapeutics is a computational drug discovery company. It develops a platform that incorporates big data, as well as AI and machine learning. Its solution helps the company discover drugs.
Type
Private
Status
Active
Founded
2003
HQ
Long Hanborough, GB | view all locations
Website
https://www.etherapeutics.co.uk/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Alan Whitmore

    Alan Whitmore, Chief Scientific Officer

  • Ali Mortazavi

    Ali Mortazavi, Chief Executive Officer and Director

  • Laura Roca-Alonso

    Laura Roca-Alonso, Chief Operating and Business Officer

  • Alison Gallafent

    Alison Gallafent, Chief Intellectual Property Officer

Operating MetricsView all

Projects Launched

12
100.0%

FY, 2016

LocationsView all

2 locations detected

  • Long Hanborough, England HQ

    United Kingdom

    Blenheim Office Park, 17 Fenlock Rd

  • Newcastle upon Tyne, England

    United Kingdom

    11 Waterloo St

e-therapeutics Financials

Summary Financials

Net income (FY, 2025)
(£14.9M)
Cash (FY, 2025)
£20.5M
EBIT (FY, 2025)
(£18.6M)

Footer menu